Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial

OBJECTIVES: Some patients with rheumatoid arthritis develop interstitial lung disease (RA-ILD) that develops into progressive pulmonary fibrosis. We assessed the efficacy and safety of nintedanib versus placebo in patients with progressive RA-ILD in the INBUILD trial. METHODS: The INBUILD trial enro...

Descripción completa

Detalles Bibliográficos
Autores principales: Matteson, Eric L., Aringer, Martin, Burmester, Gerd R., Mueller, Heiko, Moros, Lizette, Kolb, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412475/
https://www.ncbi.nlm.nih.gov/pubmed/37209188
http://dx.doi.org/10.1007/s10067-023-06623-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412475/
https://www.ncbi.nlm.nih.gov/pubmed/37209188
http://dx.doi.org/10.1007/s10067-023-06623-7

Ejemplares similares